Pediatric Oncology Non-Malignant Disorders
Categories
Protocols
P-HEMONC-CUIMC-23-040 Phase II OPEN TO ACCRUAL *
Phase 2 Study Bridging Pre-Transplant Inflammatory Dampening for Primary Immune Regulatory Disorders (BRIDGE Trial)